Dysregulation of monocytic nuclear factor-kappa B by oxidized low- density lipoprotein

Brand K, Eisele T, Kreusel U, Page M, Page S, Haas M, Gerling A, Kaltschmidt C, Neumann FJ, Mackman N, Baeuerle PA, et al. (1997)
Arterioscler. Thromb. Vasc. Biol. 17(10): 1901-1909.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Brand, K.; Eisele, T.; Kreusel, U.; Page, M.; Page, S.; Haas, M.; Gerling, A.; Kaltschmidt, ChristianUniBi; Neumann, F.J.; Mackman, N.; Baeuerle, P.A.; Walli, A.K.
Arterioscler. Thromb. Vasc. Biol.
Page URI


Brand K, Eisele T, Kreusel U, et al. Dysregulation of monocytic nuclear factor-kappa B by oxidized low- density lipoprotein. Arterioscler. Thromb. Vasc. Biol. 1997;17(10):1901-1909.
Brand, K., Eisele, T., Kreusel, U., Page, M., Page, S., Haas, M., Gerling, A., et al. (1997). Dysregulation of monocytic nuclear factor-kappa B by oxidized low- density lipoprotein. Arterioscler. Thromb. Vasc. Biol., 17(10), 1901-1909. https://doi.org/10.1161/01.ATV.17.10.1901
Brand, K., Eisele, T., Kreusel, U., Page, M., Page, S., Haas, M., Gerling, A., et al. 1997. “Dysregulation of monocytic nuclear factor-kappa B by oxidized low- density lipoprotein”. Arterioscler. Thromb. Vasc. Biol. 17 (10): 1901-1909.
Brand, K., Eisele, T., Kreusel, U., Page, M., Page, S., Haas, M., Gerling, A., Kaltschmidt, C., Neumann, F. J., Mackman, N., et al. (1997). Dysregulation of monocytic nuclear factor-kappa B by oxidized low- density lipoprotein. Arterioscler. Thromb. Vasc. Biol. 17, 1901-1909.
Brand, K., et al., 1997. Dysregulation of monocytic nuclear factor-kappa B by oxidized low- density lipoprotein. Arterioscler. Thromb. Vasc. Biol., 17(10), p 1901-1909.
K. Brand, et al., “Dysregulation of monocytic nuclear factor-kappa B by oxidized low- density lipoprotein”, Arterioscler. Thromb. Vasc. Biol., vol. 17, 1997, pp. 1901-1909.
Brand, K., Eisele, T., Kreusel, U., Page, M., Page, S., Haas, M., Gerling, A., Kaltschmidt, C., Neumann, F.J., Mackman, N., Baeuerle, P.A., Walli, A.K., Neumeier, D.: Dysregulation of monocytic nuclear factor-kappa B by oxidized low- density lipoprotein. Arterioscler. Thromb. Vasc. Biol. 17, 1901-1909 (1997).
Brand, K., Eisele, T., Kreusel, U., Page, M., Page, S., Haas, M., Gerling, A., Kaltschmidt, Christian, Neumann, F.J., Mackman, N., Baeuerle, P.A., Walli, A.K., and Neumeier, D. “Dysregulation of monocytic nuclear factor-kappa B by oxidized low- density lipoprotein”. Arterioscler. Thromb. Vasc. Biol. 17.10 (1997): 1901-1909.

63 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Dual signaling evoked by oxidized LDLs in vascular cells.
Nègre-Salvayre A, Augé N, Camaré C, Bacchetti T, Ferretti G, Salvayre R., Free Radic Biol Med 106(), 2017
PMID: 28189852
Defective Protein Catabolism in Atherosclerotic Vascular Inflammation.
Miyazaki T, Miyazaki A., Front Cardiovasc Med 4(), 2017
PMID: 29270409
New paradigms in inflammatory signaling in vascular endothelial cells.
Xiao L, Liu Y, Wang N., Am J Physiol Heart Circ Physiol 306(3), 2014
PMID: 24285111
The extrinsic coagulation cascade and tissue factor pathway inhibitor in macrophages: a potential therapeutic opportunity for atherosclerotic thrombosis.
Jiang P, Xue D, Zhang Y, Ye L, Liu Y, Makale M, Kesari S, Edgington TS, Liu C., Thromb Res 133(4), 2014
PMID: 24485401
Oxidized low-density lipoprotein suppresses expression of prostaglandin E receptor subtype EP3 in human THP-1 macrophages.
Sui X, Liu Y, Li Q, Liu G, Song X, Su Z, Chang X, Zhou Y, Liang B, Huang D., PLoS One 9(10), 2014
PMID: 25333975
Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment.
Nho K, Corneveaux JJ, Kim S, Lin H, Risacher SL, Shen L, Swaminathan S, Ramanan VK, Liu Y, Foroud T, Inlow MH, Siniard AL, Reiman RA, Aisen PS, Petersen RC, Green RC, Jack CR, Weiner MW, Baldwin CT, Lunetta K, Farrer LA, Multi-Institutional Research on Alzheimer Genetic Epidemiology (MIRAGE) Study, Furney SJ, Lovestone S, Simmons A, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, AddNeuroMed Consortium, McDonald BC, Farlow MR, Ghetti B, Indiana Memory and Aging Study, Huentelman MJ, Saykin AJ, Alzheimer's Disease Neuroimaging Initiative (ADNI)., Mol Psychiatry 18(7), 2013
PMID: 23608917
Monocytic expression of osteoclast-associated receptor (OSCAR) is induced in atherosclerotic mice and regulated by oxidized low-density lipoprotein in vitro.
Sinningen K, Rauner M, Goettsch C, Al-Fakhri N, Schoppet M, Hofbauer LC., Biochem Biophys Res Commun 437(2), 2013
PMID: 23817038
Conjugated linoleic acid isomers may diminish human macrophages adhesion to endothelial surface.
Stachowska E, Siennicka A, Baśkiewcz-Hałasa M, Bober J, Machalinski B, Chlubek D., Int J Food Sci Nutr 63(1), 2012
PMID: 21721848
OxLDL inhibits LPS-induced IFNβ expression by Pellino3- and IRAK1/4-dependent modification of TANK.
Tzieply N, Kuhn AM, Morbitzer D, Namgaladze D, Heeg A, Schaefer L, von Knethen A, Jensen LE, Brüne B., Cell Signal 24(6), 2012
PMID: 22330071
Myeloid IκBα deficiency promotes atherogenesis by enhancing leukocyte recruitment to the plaques.
Goossens P, Vergouwe MN, Gijbels MJ, Curfs DM, van Woezik JH, Hoeksema MA, Xanthoulea S, Leenen PJ, Rupec RA, Hofker MH, de Winther MP., PLoS One 6(7), 2011
PMID: 21814576
Comparison of anti-atherosclerotic effects of two different extracts from leaves of Mallotus furetianus.
Yueli L, Liqun W, Haitao W, Lianbo L, Xinan Y., Asian Pac J Trop Med 4(11), 2011
PMID: 22078950
oxLDL uptake by dendritic cells induces upregulation of scavenger-receptors, maturation and differentiation.
Nickel T, Schmauss D, Hanssen H, Sicic Z, Krebs B, Jankl S, Summo C, Fraunberger P, Walli AK, Pfeiler S, Weis M., Atherosclerosis 205(2), 2009
PMID: 19203752
Low vasa vasorum densities correlate with inflammation and subintimal thickening: potential role in location--determination of atherogenesis.
Gössl M, Versari D, Lerman LO, Chade AR, Beighley PE, Erbel R, Ritman EL., Atherosclerosis 206(2), 2009
PMID: 19368925
Increased tissue transglutaminase expression in human atherosclerotic coronary arteries.
Cho BR, Kim MK, Suh DH, Hahn JH, Lee BG, Choi YC, Kwon TJ, Kim SY, Kim DJ., Coron Artery Dis 19(7), 2008
PMID: 18923241
High tissue factor-expressing human monocytes carry low surface CD36: application to intersubject variability.
Sovershaev MA, Egorina EM, Gruber FX, Olsen JO, Osterud B., J Thromb Haemost 5(12), 2007
PMID: 17900273
Adriamycin promotes macrophage dysfunction in mice.
Asmis R, Qiao M, Rossi RR, Cholewa J, Xu L, Asmis LM., Free Radic Biol Med 41(1), 2006
PMID: 16781464
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs.
Zardi EM, Zardi DM, Cacciapaglia F, Dobrina A, Amoroso A, Picardi A, Afeltra A., Int Immunopharmacol 5(3), 2005
PMID: 15683843
Enhanced plasma levels of oxidized low-density lipoprotein increase circulating nuclear factor-kappa B activation in patients with unstable angina.
Cominacini L, Anselmi M, Garbin U, Fratta Pasini A, Stranieri C, Fusaro M, Nava C, Agostoni P, Keta D, Zardini P, Sawamura T, Lo Cascio V., J Am Coll Cardiol 46(5), 2005
PMID: 16139128
Dual role of oxidized LDL on the NF-kappaB signaling pathway.
Robbesyn F, Salvayre R, Negre-Salvayre A., Free Radic Res 38(6), 2004
PMID: 15346645
Role of vasa vasorum in transendothelial solute transport in the coronary vessel wall: a study with cryostatic micro-CT.
Gössl M, Beighley PE, Malyar NM, Ritman EL., Am J Physiol Heart Circ Physiol 287(5), 2004
PMID: 15178545
Involvement of NF-kappaB signalling in skin physiology and disease.
Bell S, Degitz K, Quirling M, Jilg N, Page S, Brand K., Cell Signal 15(1), 2003
PMID: 12401514
Hematein inhibits atherosclerosis by inhibition of reactive oxygen generation and NF-kappaB-dependent inflammatory mediators in hyperlipidemic mice.
Choi JH, Jeong TS, Kim DY, Kim YM, Na HJ, Nam KH, Lee SB, Kim HC, Oh SR, Choi YK, Bok SH, Oh GT., J Cardiovasc Pharmacol 42(2), 2003
PMID: 12883334
Anti-inflammatory properties of lipid oxidation products.
Bochkov VN, Leitinger N., J Mol Med (Berl) 81(10), 2003
PMID: 13679995
Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent.
Mempel M, Voelcker V, Köllisch G, Plank C, Rad R, Gerhard M, Schnopp C, Fraunberger P, Walli AK, Ring J, Abeck D, Ollert M., J Invest Dermatol 121(6), 2003
PMID: 14675188
The role of chemokines in human cardiovascular pathology: enhanced biological insights.
Shin WS, Szuba A, Rockson SG., Atherosclerosis 160(1), 2002
PMID: 11755926
Nuclear factor-kappaB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris.
Wilson SH, Best PJ, Edwards WD, Holmes DR, Carlson PJ, Celermajer DS, Lerman A., Atherosclerosis 160(1), 2002
PMID: 11755932
Increased IkappaB kinase activity is associated with activated NF-kappaB in acute myeloid blasts.
Baumgartner B, Weber M, Quirling M, Fischer C, Page S, Adam M, Von Schilling C, Waterhouse C, Schmid C, Neumeier D, Brand K., Leukemia 16(10), 2002
PMID: 12357358
Decreased inducibility of TNF expression in lipid-loaded macrophages.
Ares MP, Stollenwerk M, Olsson A, Kallin B, Jovinge S, Nilsson J., BMC Immunol 3(), 2002
PMID: 12366867
Chlamydia pneumoniae activates IKK/I kappa B-mediated signaling, which is inhibited by 4-HNE and following primary exposure.
Donath B, Fischer C, Page S, Prebeck S, Jilg N, Weber M, da Costa C, Neumeier D, Miethke T, Brand K., Atherosclerosis 165(1), 2002
PMID: 12208473
Oxidized low-density lipoprotein-induced apoptosis.
Salvayre R, Auge N, Benoist H, Negre-Salvayre A., Biochim Biophys Acta 1585(2-3), 2002
PMID: 12531556
Effect of hypercholesterolemia on macrophage infiltration after balloon injury to rabbit iliac artery.
Song JM, Kim HS, Park SJ, Chae IH, Oh BH, Lee MM, Park YB., Jpn Circ J 65(2), 2001
PMID: 11216820
NF-kappaB: pivotal mediator or innocent bystander in atherogenesis?
Collins T, Cybulsky MI., J Clin Invest 107(3), 2001
PMID: 11160146
[Cellular and molecular biology of atherosclerotic lesions]
Martínez-González J, Llorente-Cortés V, Badimon L., Rev Esp Cardiol 54(2), 2001
PMID: 11181311
Characterization of peroxynitrite-oxidized low density lipoprotein binding to human CD36.
Guy RA, Maguire GF, Crandall I, Connelly PW, Kain KC., Atherosclerosis 155(1), 2001
PMID: 11223422
t-Butyl hydroperoxide and oxidized low density lipoprotein enhance phospholipid hydrolysis in lipopolysaccharide-stimulated retinal pericytes.
Lupo G, Anfuso CD, Ragusa N, Strosznajder RP, Walski M, Alberghina M., Biochim Biophys Acta 1531(1-2), 2001
PMID: 11278179
The effect of endothelin-1 on nuclear factor kappa B in macrophages.
Wilson SH, Simari RD, Lerman A., Biochem Biophys Res Commun 286(5), 2001
PMID: 11527395
Activated nuclear factor-kappaB is present in the coronary vasculature in experimental hypercholesterolemia.
Wilson SH, Caplice NM, Simari RD, Holmes DR, Carlson PJ, Lerman A., Atherosclerosis 148(1), 2000
PMID: 10580167
Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis.
Gawaz M, Brand K, Dickfeld T, Pogatsa-Murray G, Page S, Bogner C, Koch W, Schömig A, Neumann F., Atherosclerosis 148(1), 2000
PMID: 10580173
Oxidized LDLs alter the activity of the ubiquitin-proteasome pathway: potential role in oxidized LDL-induced apoptosis.
Vieira O, Escargueil-Blanc I, Jürgens G, Borner C, Almeida L, Salvayre R, Nègre-Salvayre A., FASEB J 14(3), 2000
PMID: 10698969
Oxidized phospholipids activate PPARalpha in a phospholipase A2-dependent manner.
Delerive P, Furman C, Teissier E, Fruchart J, Duriez P, Staels B., FEBS Lett 471(1), 2000
PMID: 10760508
Role of reactive aldehyde in cardiovascular diseases.
Uchida K., Free Radic Biol Med 28(12), 2000
PMID: 10946210
A model to study antioxidant regulation of endotoxemia-modulated neonatal granulopoiesis and granulocyte apoptosis.
Yang KD, Chen MZ, Teng RJ, Yang MY, Liu HC, Chen RF, Hsu TY, Shaio MF., Pediatr Res 48(6), 2000
PMID: 11102554
Mildly oxidized low-density lipoproteins decrease early production of interleukin 2 and nuclear factor kappaB binding to DNA in activated T-lymphocytes.
Caspar-Bauguil S, Tkaczuk J, Haure MJ, Durand M, Alcouffe J, Thomsen M, Salvayre R, Benoist H., Biochem J 337 ( Pt 2)(), 1999
PMID: 9882624
Involvement of nuclear factor-kappaB in a murine model for the acute form of autoimmune-like toxic oil syndrome.
Bell SA, Page S, Baumgartner B, Berking C, Haas M, Eisele T, Neumeier D, Brand K., Toxicol Appl Pharmacol 157(3), 1999
PMID: 10373405
Chemokines and atherosclerosis.
Terkeltaub R, Boisvert WA, Curtiss LK., Curr Opin Lipidol 9(5), 1998
PMID: 9812193

53 References

Daten bereitgestellt von Europe PubMed Central.

NF-kappa B: a lesson in family values.
Thanos D, Maniatis T., Cell 80(4), 1995
PMID: 7867060
Function and activation of NF-kappa B in the immune system.
Baeuerle PA, Henkel T., Annu. Rev. Immunol. 12(), 1994
PMID: 8011280
NK-kappa B subunit-specific regulation of the I kappa B alpha promoter.
Cheng Q, Cant CA, Moll T, Hofer-Warbinek R, Wagner E, Birnstiel ML, Bach FH, de Martin R., J. Biol. Chem. 269(18), 1994
PMID: 8175790
Nuclear factor kappa B, a mediator of lipopolysaccharide effects.
Muller JM, Ziegler-Heitbrock HW, Baeuerle PA., Immunobiology 187(3-5), 1993
PMID: 8330898

Role of nuclear factor-kappa B in atherogenesis.
Brand K, Page S, Walli AK, Neumeier D, Baeuerle PA., Exp. Physiol. 82(2), 1997
PMID: 9129944
Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.
Brand K, Page S, Rogler G, Bartsch A, Brandl R, Knuechel R, Page M, Kaltschmidt C, Baeuerle PA, Neumeier D., J. Clin. Invest. 97(7), 1996
PMID: 8601637
Tumor necrosis factor gene expression in human vascular intimal smooth muscle cells detected by in situ hybridization.
Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS., Am. J. Pathol. 137(3), 1990
PMID: 1698022
Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop.
Hiscott J, Marois J, Garoufalis J, D'Addario M, Roulston A, Kwan I, Pepin N, Lacoste J, Nguyen H, Bensi G., Mol. Cell. Biol. 13(10), 1993
PMID: 8413223

Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans.
Rosenfeld ME, Yla-Herttuala S, Lipton BA, Ord VA, Witztum JL, Steinberg D., Am. J. Pathol. 140(2), 1992
PMID: 1739123
Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis.
Clinton SK, Underwood R, Hayes L, Sherman ML, Kufe DW, Libby P., Am. J. Pathol. 140(2), 1992
PMID: 1739124
Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions.
Yla-Herttuala S, Lipton BA, Rosenfeld ME, Sarkioja T, Yoshimura T, Leonard EJ, Witztum JL, Steinberg D., Proc. Natl. Acad. Sci. U.S.A. 88(12), 1991
PMID: 2052604
Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells.
Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM., Proc. Natl. Acad. Sci. U.S.A. 87(13), 1990
PMID: 1695010
Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.
Wilcox JN, Smith KM, Schwartz SM, Gordon D., Proc. Natl. Acad. Sci. U.S.A. 86(8), 1989
PMID: 2704749
Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells.
Drake TA, Hannani K, Fei HH, Lavi S, Berliner JA., Am. J. Pathol. 138(3), 1991
PMID: 2000938
Functional analysis of the human vascular cell adhesion molecule 1 promoter.
Neish AS, Williams AJ, Palmer HJ, Whitley MZ, Collins T., J. Exp. Med. 176(6), 1992
PMID: 1281211
Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1).
Iademarco MF, McQuillan JJ, Rosen GD, Dean DC., J. Biol. Chem. 267(23), 1992
PMID: 1379595
Expression of intercellular adhesion molecule-1 in atherosclerotic plaques.
Poston RN, Haskard DO, Coucher JR, Gall NP, Johnson-Tidey RR., Am. J. Pathol. 140(3), 1992
PMID: 1372160
Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter.
Duyao MP, Buckler AJ, Sonenshein GE., Proc. Natl. Acad. Sci. U.S.A. 87(12), 1990
PMID: 2191300
Role of oxidized low density lipoprotein in atherogenesis.
Witztum JL, Steinberg D., J. Clin. Invest. 88(6), 1991
PMID: 1752940


Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins.
Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M, Fogelman AM, Lusis AJ., Nature 344(6263), 1990
PMID: 1690354

Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate.
Parhami F, Fang ZT, Fogelman AM, Andalibi A, Territo MC, Berliner JA., J. Clin. Invest. 92(1), 1993
PMID: 8392092
Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells.
Peng HB, Rajavashisth TB, Libby P, Liao JK., J. Biol. Chem. 270(28), 1995
PMID: 7622526
Oxidized low density lipoprotein suppresses activation of NF kappa B in macrophages via a pertussis toxin-sensitive signaling mechanism.
Schackelford RE, Misra UK, Florine-Casteel K, Thai SF, Pizzo SV, Adams DO., J. Biol. Chem. 270(8), 1995
PMID: 7876078

AUTHOR UNKNOWN, Arterioscler Thromb Vasc Biol 15(), 1995
Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms.
Brand K, Mackman N, Curtiss LK., J. Clin. Invest. 91(5), 1993
PMID: 8486772
Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein.
Parthasarathy S, Steinbrecher UP, Barnett J, Witztum JL, Steinberg D., Proc. Natl. Acad. Sci. U.S.A. 82(9), 1985
PMID: 3857630
THP-1 cells form foam cells in response to coculture with lipoproteins but not platelets.
Banka CL, Black AS, Dyer CA, Curtiss LK., J. Lipid Res. 32(1), 1991
PMID: 2010692
Pyrrolidine dithiocarbamate inhibits NF-kappa B mobilization and TNF production in human monocytes.
Ziegler-Heitbrock HW, Sternsdorf T, Liese J, Belohradsky B, Weber C, Wedel A, Schreck R, Bauerle P, Strobel M., J. Immunol. 151(12), 1993
PMID: 8258705
TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown.
Schutze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kronke M., Cell 71(5), 1992
PMID: 1330325


Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

PMID: 9351352
PubMed | Europe PMC

Suchen in

Google Scholar